Boston Scientific Up on Device OK
687744
Shares of Boston Scientific (BSX:NYSE - news - research) rose Monday following the announcement that the Food and Drug Administration had approved its product to reduce the risk of a heart attack following heart bypass surgery.
162377
com October 27, 2004, 8:05 AM PT. ZDNet&#39;s survey of IT professionals in October kept upgrading hardware at number two on the businesses radar throughout the year.
240324
Optimism that the embattled technology sector was ripe for a recovery sent stocks modestly higher yesterday, despite a new revenue warning from semiconductor company Broadcom Inc.
767917
Boston Scientific Corp.  on  Thursday issued preliminary sales and earnings results for the  third quarter below Wall Street expectations and its shares  fell more than 3 percent in after-hours trading.
210234
com October 7, 2004, 9:01 PM PT. With the economy slowly turning up, upgrading hardware has been on businesses radar in the past 12 months as their number two priority.
311263
Boston Scientific Corp. BSX.N, whose  Taxus heart device has been involved in a major recall, said on  Wednesday preliminary August sales of the device slowed to $200  million from $207 million reported in July, and issued an  outlook that was below Wall Street estimates.
598366
roundup Plus: HP partners with 3G gear maker...AMD starts shipping 90-nanometer chips...ABC.com to air on Real's SuperPass.
679085
Yesterday's release by Dell Computer of very preliminary earnings numbers for its previous fiscal quarter may give investors at least a handful of data to help them understand the turmoil from which it may be recovering...if it is recovering. The company doesn't appear to be hemorrhaging, and there seems to be at least some good news. But it's hard not to keep seeing question marks and unresolved issues.
308614
Boston Scientific provided fresh evidence in its strong quarterly earnings report Tuesday that it reigns supreme in the market for drug-coated stents.
288719
com October 18, 2004, 4:57 PM PT. ZDNet&#39;s survey of IT professionals in October kept upgrading hardware at number two on the businesses radar throughout the year.
593671
Plus: Dell delays...Novell profit climbs...Symbian spurt continues...HP profit surges. Check back for latest.
631705
Plus: Intel remains optimistic...IBM tops estimates...GameStop raises earnings estimates...RIM profits up on expanded customer base...Palm's losses continue.
23758
Medtronic Inc. (MDT.N: Quote, Profile, Research) on Wednesday said its quarterly earnings rose on surprisingly brisk demand for devices that slow racing heartbeats, offsetting a weaker-than-expected performance in some ...
156096
Boston Scientific Corp. (BSX.N: Quote, Profile, Research) , whose Taxus heart device has been involved in a major recall, said on Wednesday preliminary August sales of the device slowed
685438
Plagued by chronic bad news about its marquee cardiovascular products, Boston Scientific Corp. yesterday moved to shift Wall Street's focus to a strong, solidly growing part of its business: Endoscopy products used in treating everything from kidney stones to throat and digestive-tract cancers.
371532
Boston Scientific Corp. yesterday said regulators finished inspecting an Irish production facility that makes its problem-plagued cardiac stent systems and did not report flaws there, a potential step forward for the medical devices giant after three safety recalls.
73767
Plus: IBM, Yahoo post high...AMD posts loss...Sony TV unit struggling...Nokia on upswing...Apple beats expectations.